Author:
Adams Emma A,Yang Justin C,O’Donnell Amy,Minot Sarah,Osborn David,Kirkbride James B
Abstract
Abstract
Background
Opioid use is a major public health concern across the globe. Opioid use and subsequent access to care is often shaped by co-occurring issues faced by people using opioids, such as deprivation, mental ill-health, and other forms of substance use. We investigated the role of social deprivation and comorbid mental health diagnoses in predicting re-engagement with substance use services or contact with crisis and inpatient services for individuals with opioid use disorder in secondary mental health care in inner-city London.
Methods
We conducted a prospective cohort study which followed individuals diagnosed with a first episode of opioid use disorder who accessed substance use services between September 2015 and May 2020 for up to 12 months, using anonymised electronic health records. We employed negative binominal regression and Cox proportional survival analyses to assess associations between exposures and outcomes.
Results
Comorbid mental health diagnoses were associated with higher contact rates with crisis/inpatient services among people with opioid use disorder: incidence rate ratios (IRR) and 95% confidence intervals (CI) were 3.91 (1.74–9.14) for non-opioid substance use comorbidity, 8.92 (1.81–64.4) for a single comorbid mental health diagnosis, and 15.9 (5.89–47.5) for multiple comorbid mental health diagnoses. Social deprivation was not associated with contact rates with crisis/inpatient services within this sample. Similar patterns were found with time to first crisis/inpatient contact. Social deprivation and comorbid mental health diagnoses were not associated with re-engagement with substance use services.
Conclusion
Comorbid substance and mental health difficulties amongst people with an opioid use disorder led to earlier and more frequent contact with crisis/inpatient mental health services during the first 12 months of follow up. Given the common co-occurrence of mental health and substance use disorders among those who use opioids, a better understanding of their wider needs (such as social, financial and other non-medical concerns) will ensure they are supported in their treatment journeys.
Funder
School for Public Health Research
NIHR Applied Research Collaboration North East and North Cumbria
NIHR
University College London Hospitals Biomedical Research Centre
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Health Policy
Reference36 articles.
1. United Nations Office on Drugs and Crime. World Drug Report. 2022: Booklet 3 Drug Market Trends Cannabis Opioids. United Nations publications; 2022. Available from: https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_3.pdf.
2. The Lancet Public Health. Opioid Overdose crisis: time for a radical rethink. Lancet Public Health. 2022;7(3):e195. https://doi.org/10.1016/S2468-2667(22)00043-3.
3. Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS ONE. 2019;14(8):e0221153. https://doi.org/10.1371/journal.pone.0221153.
4. Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid Overdose crisis. Curr Opin Psychiatry. 2021;34(4):344.
5. Halpin J, Mattson C, Goldberger B, Gladden R. Deaths involving fentanyl, fentanyl analogs, and U-47700 10 States, July December 2016. MMWR Morb Mortal Wkly Rep. 2017;66:1197–202.